FDA Announces Proposed Collection of Information for Electronic Drug Product Reporting of Human Drug Compounding Outsourcing Facilities

Summary

The Food and Drug Administration (FDA) is seeking public comment on a proposed collection of information related to electronic reporting of human drug compounding outsourcing facilities, as required by the Paperwork Reduction Act of 1995, and has submitted the request for review to the Office of Management and Budget (OMB)